We 
Introduction
Two possible consequences of parotidectomy are Frey 's syndrome and fac ial contour deformity:
• Frey's syndrome is generally believed to be caused by an aberration in the regrowth of the postganglionic parasympathetic fibers that normally supply the pa rotid gland. This aberration results in their innervation of the sweat glands ofthe skin.' The reported inc idence of Frey's syndrome follo wing parotidectomy has vari ed greatly among different studies; when no prev enti ve steps were taken, the incidence has been reported to be as low as 6%2 and as high as 96%. • Faci al contour deformity frequently occurs as a result of a surg ically cre ated mild depression in the pre-and infraaur icular area.
Several intraoperative techniques ha ve been used in an atte mpt to prevent both of these consequences. Among them are thick skin flap elevation. ' fascia lata grafts,' > derm al-fat gra fts.?" sternocleidomastoid muscle (SCM) flap s,S· lO superficial mus culoaponeuroti c system (SMAS) flaps ,\,II and temporoparietal fascia flaps. F-! '
We conducted a study to test the effectiveness of SCM flap reconstruction in preventing Frey's syndrome and facial contour deformities in patients who underwent superficial parotidectomy.
Patients and methods
This prospective study was conducted on 24 pat ients who had benign les ions of the parotid gland. Twelve patients we re randomly selected to undergo superficial parotidectomy wi th SCM flap reconstruction and 12 without reconstruction .
The flap group was made up of7 men and 5 women aged 34 to 65 ye ars (mean: 49) , and the nonflap group included 7 women and 5 men aged 29 to 71 years (mean: 50) .
Following the parotidectomy, the len gth of the surgical defect that required reconstruction wa s measured from the ma stoid tip . Superior SCM flaps were raised to a distance approxi mately one-third the w idth ofthe muscle and onethird to one-half of its length. Caution wa s exercised to avoid injuring the accessory nerve during mobilization of the SCM . Th e elevated flap was brought to the surgical area and sutured to the edge of the SMAS that cov ered the fa cial nerve. We intended to leave no area uncovered in the surgical bed.
Postoperative follow-up ranged from 9 to 32 months in the flap group (mean: 15.4) and 10 to 48 months in the nonfl ap gro up (m ean : 26. 2) . At follow-up , all patients ASAL , KOYBAf/IOGLU, INAL, URAL, USLU, CEYLAN, ILERI completed a Sh0l1 questionnaire survey and underwent a starch-iodine test.
The survey was made up of two primary questions:
• Do you experience abnormal sweating, flushing, or facial warmth while eating?
• Are you pleased with the cosmetic outcome of the surgery?
The questionnaire contained one secondary inquiry: Do you have trouble with the movement of your neck or shoulder?
In addition, all patients were evaluated for Frey's syndrome via the starch-iodine test. This test was performed on both sides of the face , the nonoperated side serving as a control. The pre-and infraauricular areas were painted with 10% iodine solution and left to dry. Afterward, cornstarch was spread overthe painted areas. Patients were then given lemon candy to suck , and the results were visually evaluated by an otolaryngologist who was blinded to the type of surgery. Positivity for Frey 's syndrome on the starch-iodine test was classified as either mild, moderate, or strong according to criteria established by Taylor et al."' The presence of a punctate discoloration of the parotid region was considered mildly positive, a patch of discoloration 2 ern?or smaller was classified as moderately positive, and a patch larger than 2 em -indicated a strongly positive result.
Results
Frey's syndrome. According to the questionnaire responses , none ofthe 24 patients experienced abnormal facial sweating, flushing, or warmth while eating. However, the starch-iodine test on the operated side was mildly positive in 6 ofthe 12 patients (50%) in the nonflap group, whereas none ofthe patients in the flap group had a positive result. The difference between the two groups was statistically significant (p < 0.05). No patient in either group had a positive test on the nonoperated side.
Facial contour deformity. All patients indicated on the questionnaire that they were pleased with the cosmetic result. This was despite the fact that an otolaryngologist who had been blinded to the type of surgery observed a mild pre-and infraauricular depression in 6 patients (50%) in the flap group and 7 (58%) in the nonflap group.
No patient reported any functional impairment on the questionnaire, and no postoperative complication related to facial nerve or accessory nerve function was observed in any patient. creates a barrier between the exposed postganglionic parasympathetic nerve fibers and the sweat glands of the overlying skin flap. In add ition to preventing Frey's syndrome, some of these procedures help preserve the facial contour by filling the surgical defect.
Discussion
The use of the SMAS flap for the prevention of Frey 's syndrome has been widely reported in the literature. Allison and Rappaport compared 112 patients who underwent SMAS interposition with a control group of 44 patients who did not." They found that the incidence of Frey's syndrome was 0.8% in the SMAS group and 83% in the control group.
In a retrospective review ofparotidectomy results in 21 patients, Kim and Mathog compared the traditional technique with the rotation and advancement of a combined platysma muscle-cervical fascia-sternocleidomastoid flap (PCS flap). " They observed symptoms of Frey's syndrome in 22% of the PCS flap patients and 50% of the nonflap patients. They also found that the PCS flap prevented deformity, In a study of 160 patients who had undergone total or subtotal parotidectomy with an SMAS flap , Bonanno et al reported that the incidence of Frey's syndrome was 0% according to starch-iodine testing." They recommended that the SMAS flap be considered the standard of care for preventing Frey's syndrome in postparotidectomy patients.
Taylor et al studied Frey's syndrome after superficial parotidectomy by comparing patients who had undergone subcutaneous or sub-SMAS elevation." They reported no significant difference in the incidence of Frey's syndrome, in the amount of elapsed time until the development of symptoms, and in the severity of symptoms in the two groups . Singleton and Cassisi pointed out the importance of using a thick skin flap during parotidectomy as a means of preventing Frey's syndrome. ' Anatomically, the SMAS lies directly over the parotid fascia , and it is therefore usually resected along with the parotid gland. Therefore, the SMAS flap technique is not advisable when preservation ofthe SMAS may compromise the margins ofthe parotidectomy resection, as occurs when large or anterior neoplasms of the gland are present. 10 On the other hand, the use of the SMAS flap does not prevent facial contour deformity,
The interposition of a vascularized temporoparietal fascia flap between the parotid bed and the overlying skin following superficial parotidectomy has been used to prevent both Frey 's syndrome and facial contour defects." :"
Ahmed and Kolhe used a double-layer superficial temporal artery fascia flap , made up of the temporoparietal fascia and the fascia over the temporal is muscle, for the prevention of Frey 's syndrome and contour defect. 17 They reported that the incidence of Frey 's syndrome was sig-
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nificantly lower and the volume deficit was less not iceable in these pat ients than in those who did not undergo flap reco nstruc tion. Th e adva ntages of the temp oroparietal fasc ia flap are its thinness, pliabi lity, and good vascularity. However, this tech nique does pose a risk of inj ury to the fronta l branch of the facia l nerve because the ner ve trave ls w ithi n the plane adjacent to the temporoparietal fascia flap. Another complication of this procedure is scalp alopecia. Treatment ofFrey 's syndrome. Onc e Frey 's syndrome is present, it can be treated eit her medica lly or surgically. Medical trea tme nt inclu des topical anticholinerg ic or antipe rspi rant crea ms and lot ions. However, these treatmen ts are sometimes unsatisfactory because ( I) they provide only temporary relief, (2) they are vis ible when appl ied, (3) they are less effective in the hairy temporal area, and (4) they cause various side effects, inc ludi ng loca l irritation of the skin and the sweat duct epithelium .IS Mo reover, although topical anticholinergics have been shown to be effecti ve in controlling gusta tory sweati ng, they can be absorbed systemically and cause blurred vision , dry mouth , urinary retentio n, tac hycardia, and allergy.'? Botulinum A toxin has also been reported to be useful in the treatm en t of Frey 's syndrome .i" Surgical treat me nt of Frey 's syndro me w ith tymp ani c neur ectomy is aimed at interrupti ng the parasympat hetic fibers as they cross the tympanic promontory. Tympanic ne urectomy has been reported to be successful in approximate ly 80% of cas es,2! ·22 but its use is limited beca use it requ ires a secondary intervention.
Several impla nt materials (e.g., lyophil ized dura mater, po lyg lactin 9 1O/po lydioxanone, and expa nded polytetrafluoroethylene) have bee n used as a mec hanical bar rier to prevent postoperative Frey's syndro me ; Dul guerov et al reported that these impl ants lowered the inciden ce of Frey's sy ndro me to 3%.23 Fascia lata has been interposed successfully as a barrier, but it is not as effective in correcti ng vo lume defects.v' Prevention offacial contour deformity. Free abdomina l derma l-fat grafts have been used to pre vent facial co nto ur deformities.v" This type of graft not only res ults in a good cos metic resu lt, it also serves as a barrier to rege nerat ing neuro ns. Th e disadvantages oft his procedur e are th at it requi res anot her incision and it poses a risk of fat reso rption. Cas ler and Conley assessed postoperative Frey's syndrome in three groups of patient s: an SCM flap group, an SMAS plic ation group, and a control group in which no surgical preventive measures were taken.' They found that the incidence of Frey 's syndrome was 47.1% in the control gro up, 12.5% in the SCM flap group , and 0% in SMAS plication group . The difference between the SCM flap group and the SMAS plication group was not statistically signific ant.
In our stud y, the inciden ce ofaberrant cross -innervation determined objectively by the starch-iodin e test was 0% in the SCM flap group and 50% in the nonflap gro up-a statistically significant difference (p < 0.05) . Hann and Suen have postulated that the incidence ofFrey's syndrome would be higher that what is generally reported if clinicians would actively sear ch for it by asking patients direct symptomspecific questions." In our study, no patient report ed any symptoms related to the aberrant cros s-innervation on our questionnaire, even thoug h some of them had a positive starch -iodine test.
All patients in our stud y were pleased with the cosm etic outcome , eve n thos e who had mild deformities. Finally, we observed no postoperative complications.
In conclusion , we believe that SCM flap reconstru ction during parotid surgery is an effective method of covering the surgical defect and possibly preventing Frey's syndrome. Th e rotated flap must cover the entire surgica l bed so that no distal branch of the facia l nerve is exposed. Close attention to this surgical detail will result in a more successful outcome.
Althou gh the only significant difference between our two groups of patients involved reinnervation patterns rather than self-reported manifestations of Frey 's syndrome, we maintain that SCM flap recon struction is still advantageous because it does have the potential to prevent Frey's syndrome. Moreo ver, it is an easy procedure to perform , it is not time-con sumin g, and it does not require any additional inci sions.
